Back
CG Oncology, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
CGON
CG Oncology, Inc.
Last Price:
$43.29
Seasonality Move:
-29.45%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCG Oncology, Inc. Stock Forecast
-
Is CG Oncology, Inc. Stock Undervalued?The current CG Oncology, Inc. [CGON] share price is $43.30. The Score for CGON is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
CGON is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will CG Oncology, Inc. Stock Go Up Next Year?
Data Unavailable
CG Oncology, Inc. Stock Rating
Data Unavailable
CG Oncology, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cgoncology.com
52-Week Data
52-Week High:
46.01
52-Week Low:
14.80
Prediction Charts
Market Cap:
3.3B
Price in USD:
43.30
Volume:
745.5K
Beta:
1.36
Technical Analysis
SMA50:
41.66
SMA100:
35.37
SMA200:
30.19
52-Wk Change:
29.02%
Stock Predictions
-
Is CG Oncology, Inc. stock public?Yes, CG Oncology, Inc. is a publicly traded company.
-
What is the CG Oncology, Inc. stock quote today?The CG Oncology, Inc. stock price is 43.30 USD today.
-
How to buy CG Oncology, Inc. stock online?You can buy CG Oncology, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 41.43 | 41.25 | 42.90 | 39.21 |
| Nov-18 | 40.93 | 42.55 | 43.73 | 39.34 |
| Nov-19 | 42.78 | 42.60 | 43.79 | 41.98 |
| Nov-20 | 43.12 | 40.71 | 44.56 | 40.64 |
| Nov-21 | 40.26 | 42.44 | 42.55 | 40.06 |
| Nov-24 | 43.08 | 43.56 | 44.50 | 42.56 |
| Nov-25 | 43.52 | 45.51 | 45.56 | 43.05 |
| Nov-26 | 45.47 | 44.84 | 45.78 | 44.27 |
| Nov-28 | 45.25 | 44.84 | 45.94 | 44.27 |
| Dec-1 | 44.20 | 43.25 | 45.28 | 43.14 |
| Dec-2 | 43.35 | 41.37 | 43.97 | 41.35 |
| Dec-3 | 41.42 | 42.61 | 43.00 | 41.24 |
| Dec-4 | 42.51 | 44.73 | 45.12 | 41.55 |
| Dec-5 | 45.05 | 43.30 | 46.01 | 43.02 |
CG Oncology, Inc. Earnings
Data Unavailable
CG Oncology, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and a decrease next year of $0.46 per share.
* CG Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.